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IT HAS LONG BEEN KNOWN THAT blood pressure fluctuates around an average level of blood pressure (9, 17, 33) . Furthermore, the physiological mechanisms that stabilize blood pressure within narrow limits around a given set point, such as local vascular mechanism, cardiovascular reflexes, the renin-angiotensin aldosterone system, and others, are well characterized (19) . However, it is understood only recently that these same mechanisms that are responsible for maintaining blood pressure within narrow limits also introduce a certain amount of blood pressure variability (BPV) that is typically of relatively small amplitude (27) . Depending on the inherent time delays in the various mechanisms contributing to blood pressure control, this variability can consist of fast (higher frequency) or slow (lower frequency) fluctuations in arterial blood pressure (27) . Accordingly, overall BPV has been classified into high-frequency (HF), low-frequency (LF), and very LF (VLF) BPV.
HF BPV appears to be largely related to respiratory fluctuations in stroke volume and cardiac output (36) . LF BPV (also referred to as Mayer waves or mid-frequency BPV) is largely under the influence of the arterial baroreceptor reflex (2, 3, 11) and sympathetic modulation of vascular tone (28 -30) .
Surprisingly little is known about the mechanisms generating VLF BPV. Over a decade ago, it had been suggested that the renin-angiotensin aldosterone system may contribute importantly to VLF BPV (7, 20, 21) . Furthermore, studies from our laboratory demonstrated that VLF BPV depends on L-type Ca 2ϩ channels (16) and suggested that myogenic vascular function contributes significantly to VLF BPV (31) . One importance of these findings is that cerebrovascular myogenic function normally protects the brain from hemorrhagic stroke and that a loss of myogenic vascular function [e.g., in chronic renal failure (15, 18) ] constitutes an important risk factor for hemorrhagic stroke (25, 26) . Due to the postulated contribution of myogenic vascular function to VLF BPV (31) , increased risk for hemorrhagic stroke may be detected by reduced VLF BPV. Indeed, VLF BPV is reduced in stroke-prone spontaneously hypertensive rats compared with stroke-resistant spontaneously hypertensive rats (31) . However, the concept that VLF BPV primarily reflects myogenic vascular function and/or autoregulation of blood flow and, therefore, predicts hemorrhagic stroke in subjects with reduced VLF BPV is currently not generally accepted (12) .
Specifically, a limitation of our laboratory's previous studies (16, 31) was that the conclusion that myogenic vascular function contributes significantly to VLF BPV was based on experiments utilizing the L-type Ca 2ϩ channel blocker nifedipine. As pointed out in our laboratory's previous papers (16, 31) , L-type Ca 2ϩ channels are also involved in the vascular actions of vasoactive substances, such as catecholamines. Thus a potential role of the sympathetic nervous system and the sympathetic component of the baroreceptor reflex for modulation of VLF BPV could not be ruled out in our previous studies (12) . The current study was designed to overcome this limitation by not relying on the use of L-type Ca 2ϩ -channel blockers. The effect of myogenic vascular responses and/or autoregulation of blood flow on blood pressue can best be described as a positive feedback mechanism. An increase in blood pressure causes myogenic vasoconstriction, which limits pressure-induced increases in blood flow. However, this vasoconstriction also increases vascular resistance and, therefore, further increases blood pressure. Contrary, a decrease in blood pressure causes myogenic vasodilatation, which reduces vascular resistance and, therefore, further reduces blood pressure. Because of this positive feedback mechanism, fluctuations in blood pressure are amplified by autoregulatory mechanisms such as myogenic vascular responses. This amplification of spontaneous blood pressure fluctuations gives rise to "myogenic-medi-ated BPV." Thus, by identifying the dynamic properties of "whole body autoregulation of blood flow," it becomes possible to determine the frequency range of BPV that is modulated by myogenic vascular function.
In rats, the dynamic properties of autoregulation of blood flow have been studied in a variety of local vascular beds, including the renal (1, 4, 5, 10, 13) , the mesenteric (1), and the cerebral (14) circulation. These studies demonstrated that dynamic autoregulation of blood flow in rats operates up to ϳ0.2 Hz in the renal circulation, up to ϳ0.13 Hz in the mesenteric vasculature, and up to ϳ0.1 Hz in the cerebral vascular bed. The impact of autoregulation of blood flow on BPV, however, depends on the integrated response of all vascular beds of the circulation, which may not simply be the average of the response in individual vascular beds. To study this integrated response, we used computer-regulated cardiac pacing to elicit blood pressure oscillations at eight frequencies ranging from 0.016 to 0.5 Hz and recorded the resulting oscillations in cardiac output. This approach allowed us to determine the frequencies at which whole body autoregulation of blood flow is most effective in buffering pressure-induced oscillations in cardiac output and, therefore, to test our hypothesis that the frequency response characteristic of whole body autoregulation of blood flow is consistent with the frequency range of VLF BPV in rats.
METHODS

Animals
Experiments were performed in 11 male Sprague-Dawley rats (Harlan, Indianapolis, IN) at an age of 16 Ϯ 2 wk and a body weight of 377 Ϯ 22 g. Rats were housed in clear plastic cages, and temperature (21 Ϯ 2°C) and light periods (12-h light-dark cycle; light on between 6:00 AM and 6:00 PM) were controlled. A standard rat chow and tap water were provided ad libitum. Experiments were performed in accordance with the "Guiding Principles for Research Involving Animals and Human Beings" of the American Physiological Society (35) and have been approved by the Institutional Animal Care and Use Review Committee of The University of Iowa.
Instrumentation
During instrumentation and during experiments, rats were placed on a temperature-controlled heating pad (model K-20, American Medical Systems, Cincinnati, OH) to prevent hypothermia. After anesthesia (isoflurane, induction 5% in room air, maintenance 2% in room air), catheters were inserted in the right femoral artery and vein and in the left jugular vein. Thereafter, a cardiac pacing electrode was inserted into the right ventricle through the right jugular vein and a ground electrode was placed subcutaneously on the left side of the thorax. The pacing electrode consisted of a flexible multi-stranded insulated silver wire (AS155-30, Cooner Wire, Chatsworth, CA) from which the insulation was removed for a length of 3 mm at the tip. The ground electrode consisted of a round metal pad of 4-mm diameter that was insulated on the side facing the skeletal muscle to avoid muscle twitches during pacing. Next, the trachea was cannulated, and artificial ventilation was initiated [60 breaths/min, 2-ml tidal volume, positive end-expiratory pressure (PEEP), Harvard rodent ventilator model 683]. Finally, an ultrasound flow probe (model 2PSB, Transonic Systems, Ithaca, NY) was placed around the ascending aorta through a right parasternal incision. The ultrasound device (model TS420, Transonic Systems, Ithaca, NY) is a transit time flowmeter that provides absolute blood flow values, calibrated in milliliters per minute. The design of this system is such that it provides accurate absolute flow values even if the vessel diameter changes during an experiment. The thoracic cavity remained open throughout the experimental protocol, and the incision sites were covered with salinesoaked gauzes to prevent tissue dehydration.
Experimental Protocol
After instrumentation anesthesia was switched to 1% isoflurane in oxygen for the remainder of the experiment. Arterial blood pressure (via catheter in right femoral artery, P23 ID Gould-Statham transducer, Gould Series 4000 amplifier), heart rate (derived from blood pressure signal), and cardiac output (Model TS420, Transonic Systems, Ithaca, NY) were recorded at a sampling rate of 500 Hz using the freely available HemoLab data acquisition software (http://www.harald. nxserve.net/HemoLab/HemoLab.html). Intravenous infusion of 0.9% saline (1 ml/h via catheter in right femoral vein) was started, and baroreceptor-heart rate reflex testing was performed by a series of intravenous bolus injections (via catheter in left jugular vein) of increasing doses of phenylephrine (first dose 2.0 g/kg, subsequent doses doubled until no further increase in blood pressure was achieved) and sodium nitroprusside (first dose 0.2 g/kg, subsequent doses doubled until no further decrease in blood pressure was achieved). Between each bolus injection, sufficient time was provided to reestablish baseline blood pressure and heart rate values. After baroreflex testing and after stable baseline conditions were reestablished, blood pressure oscillations were induced by computer-regulated cardiac pacing. In eight cardiac pacing sequences, blood pressure oscillations at frequencies ranging from 0.016 to 0.5 Hz were induced in ascending order of frequency. The duration of each sequence was adjusted to obtain a minimum of 10 full cycles at each frequency. The specific parameters for the cardiac pacing protocol are provided in Table 1 . Baroreceptor heart rate reflex testing and the computer-regulated cardiac pacing protocol were repeated during intravenous infusion of phenylephrine (1 mg ⅐ ml Ϫ1 ⅐ h Ϫ1 ), which has been demonstrated to facilitate myogenic vascular function (6, 34) . The order of application of the eight individual frequencies of pacinginduced BPV was the same for control conditions and ␣ 1-adrenergic receptor stimulation to standardize the time interval between application of individual frequencies of pacing-induced BPV during the two experimental conditions. A limitation of this approach is that a potential time effect on the vascular responses to pacing-induced BPV cannot totally be excluded.
Computer-Regulated Cardiac Pacing
The software for computer-regulated cardiac pacing is included with the freely available HemoLab data acquisition software. This Eight cardiac pacing sequences were applied in ascending order of the frequency of the induced blood pressure oscillations (frequency). The recording time for each sequence (duration) was adjusted for the cycle length of the blood pressure oscillations (period) to obtain a minimum of 10 full cycles (no. of periods) for each frequency. Transfer function analysis was performed on 50% overlapping segments of a number of data points (no. of values for FFT) that was adjusted for the cycle length of the induced blood pressure oscillations. Time length of these overlapping segments is provided in parentheses.
software extracts the beat-by-beat mean blood pressure values from the arterial blood pressure signal and uses them as input for a software-based proportional integral-derivative (PID) regulator. The regulator drives a transmitter module (connected to the USB-port of the computer) that sends the pacing frequency via radio telemetry to a receiver that is part of a battery-operated pacemaker module that connects to the implanted pacing and ground electrodes. The setpoint of the regulator can be defined as a constant value, as periodic sine, rectangular, or triangular waveforms, or as combinations thereof. The regulator will then automatically adjust the pacemaker frequency so that mean blood pressure follows the predetermined waveform. Since we did not induce atrio-ventricular block, the pacing frequency needed to be higher than the endogenous heart rate to prevent intermittent endogenous heart beats during cardiac pacing. At pacinginduced blood pressure oscillations with low frequencies, an increase in pacing frequency will reduce blood pressure (Figs. 1 and 2) most likely due to reduced cardiac filling and thus reduced stroke volume. Therefore, we defined the set point of the regulator as periodic sine waves with mean blood pressure levels of 10 -20 mmHg below the spontaneous mean blood pressure of each individual rat and with amplitudes of 20 mmHg. The frequency of the induced blood pressure oscillations varied from 0.016 up to 0.5 Hz as indicated in Table 1 .
Inasmuch as we are controlling cardiac output (via changes in heart rate) in a manner that ensures that mean arterial pressure changes in a sinusoid, the meaning of the term "the response of cardiac output to a change in mean arterial pressure" is clarified as follows. In a passive, rigid system, a sinusoidal change in cardiac output would produce a sinusoidal change in mean arterial pressure in a 1:1 ratio as percent change. Thus when activated to produce a sinusoid in mean arterial pressure, the computer begins to drive cardiac output in a sinusoid. Once a vascular reaction occurs (passive and/or active), the computer needs to further modify cardiac output from a 1:1 ratio with respect to mean arterial pressure to maintain mean arterial pressure on a sinusoidal trajectory and must do so in proportion to any changes in vascular conductance elicited by the change in mean arterial pressure. It is this continuous, computer-imposed modification of cardiac output from a 1:1 sinusoidal pattern that constitutes our "response of cardiac output to mean arterial pressure."
Data Analysis
Baroreflex testing. For baroreflex testing, systolic blood pressure and heart rate were extracted from the arterial pulsatile blood pressure signal. For each rat and for both experimental conditions (saline or phenylephrine infusion), the maximal changes in systolic blood pressure and heart rate in response to the bolus injections of phenylephrine and sodium-nitroprusside were determined and plotted in an x/y diagram with changes in systolic blood pressure on the x-axis and changes in heart rate on the y-axis. For statistical data analysis, a linear regression line was fitted through the linear portion of the x/y diagram, and the slope of this regression line was used as a measure of baroreceptor heart rate reflex sensitivity. For graphical representation, data were grouped by the amount of change in systolic blood pressure in 10-mmHg increments (e.g., 0 -9, 10 -19, 20 -29) . For each grouped range of systolic blood pressure values, the averaged heart rate responses from all rats were plotted (y-axis) against the grouped ranges of systolic blood pressure values (22) .
Transfer function analysis. From the original data files the, 8 individual cardiac pacing sequences (Table 1) were extracted for the control condition (saline infusion) and for ␣ 1-adrenergic receptor stimulation (phenylephrine) resulting in 16 data files per rat. From these data files (sampling rate 500 Hz), systolic, mean, and diastolic blood pressure, heart rate, and mean cardiac output were derived on a beat-by-beat basis. Total vascular conductance was computed from these beat-by-beat values as mean cardiac output divided by mean blood pressure. Finally, the beat-by-beat time series were interpolated (cubic spline) and resampled at 15 Hz to convert non-equidistant time series into equidistant time series. From these 15-Hz time series, mean values were calculated for mean blood pressure, heart rate, cardiac output, and vascular conductance for statistical data analysis.
Transfer function analyses between mean blood pressure (input) and cardiac output (output) and between mean blood pressure (input) Fig. 1 . Original recordings of arterial blood pressure (BP), heart rate (HR), and cardiac output (CO) obtained during control conditions from one rat for all eight sequences of pacing-induced BP oscillations with frequencies (f) ranging from 0.016 to 0.5 Hz, corresponding to cycle lengths () of 60 s down to 2 s. Note that mean CO (white lines in CO graphs) is relatively constant despite the pronounced BP oscillations, especially at lower BP oscillation frequencies. This may be seen as an indication of autoregulation of CO. and total vascular conductance (output) were performed using an algorithm based on the fast Fourier transform (8, 30, 31) . Briefly, the squared coherence function ␥ 2 (q) and the phase ⌽(q) and gain H(q) of the transfer functions were calculated on the basis of the autospectral density functions and the cross-spectrum of the input (mean arterial blood pressure) and output (cardiac output or total vascular conductance) functions. Mean arterial blood pressure was used as input function because myogenic autoregulatory vascular responses are relatively slow. Owing to the integrating properties of the cardiovascular system, we assume that mean arterial blood pressure is the driving force that elicits myogenic autoregulatory vascular responses in vivo. The squared coherence ␥ 2 (q) function is unitless, and its values can range from 0 to 1. It describes the degree to which the input and output functions are correlated with each other. A value of 0 indicates no correlation, whereas a value of 1 is consistent with perfect correlation. A value of Ͼ0.5 is generally accepted as significant correlation because a squared coherence value of 0.5 suggests a relation between two signals based on 50% shared variance (32) . The gain of the transfer function H(q) is a measure of how much the output function changes for a given change in the input function. Finally, the phase of the transfer function ⌽(q) is a measure of the time delay between a change in the input function and the resulting change in the output function.
Interpretation of transfer function gains. We also calculated the normalized gains of the transfer functions by multiplying the absolute gains with total peripheral resistance or with the product of total peripheral resistance and mean blood pressure for the transfer functions between mean blood pressure and cardiac output and between mean blood pressure and vascular conductance, respectively. These normalized gains are unitless. In a totally stiff vasculature, the normalized gain of the transfer function between mean blood pressure and cardiac output would be 1 (cardiac output follows pressure passively), whereas the normalized gain of the transfer function between mean blood pressure and vascular conductance would be 0 (no passive distention or recoil in response to pressure changes). In a compliant vasculature (that distends or recoils in response to pressure changes) the normalized gain of the transfer function between mean blood pressure and cardiac output is Ͼ1, and the normalized gain for the transfer function between mean blood pressure and vascular conductance is Ͼ0. Autoregulation of blood flow will lower the normalized gains of the transfer functions in compliant vessels because there is less change in cardiac output for a given pressure change and because the passive distention or recoil in response to pressure changes are opposed by myogenic constriction or myogenic dilation. In contrast, activation of the baroreceptor reflex would increase the normalized gains of the transfer functions in a compliant vasculature because an increase in pressure would cause reflexmediated vasodilation (which amplifies the effects of passive distention), and a decrease in pressure would elicit reflex-mediated vasoconstriction (which amplifies the effects of passive recoil).
Statistics
All data are presented as means Ϯ SE. Statistical comparisons between experimental conditions (NaCl vs. phenylephrine infusion) and between different frequencies of pacing-induced blood pressure oscillations were done by two-way ANOVA for repeated measures calculated by the regression approach (24) that better accounts for missing values in repeated-measure designs (23) . For the normalized gains and the phases of the transfer functions, post hoc signed-rank Wilcoxon tests were performed for individual comparisons of data obtained at different frequencies of pacing-induced blood pressure oscillations if there was statistical significance in the two-way ANOVA. Visual inspection of the normalized gains of the transfer functions revealed inflection points at frequencies below and above 0.1 Hz, where the normalized gain abruptly increased or decreased from more constant values around 0.1 Hz. These inflection points (arrows in Figs. 3 , 5, and 6) were determined as the first significant (P Ͻ 0.1) difference of pairwise comparisons between gains of consecutively increasing or decreasing frequencies, starting at a center frequency of 0.1 Hz. Other than for determination of inflection points, statistical significance was assumed at P Ͻ 0.05.
RESULTS
The ␣ 1 -adrenergic receptor stimulation protocol could only be performed in 8 of 11 rats because hemodynamic parameters were unstable in 3 rats after completion of the control experiment. In 3 of the 11 rats that completed the control experiment and in 2 of the 8 rats that also completed the ␣ 1 -adrenergic receptor stimulation protocol, some pacing sequences could not be used because of low recording quality. Therefore, the number of animals for the individual pacing sequences varied between 8 and 11 in the control experiments and between 6 and 8 for the ␣ 1 -adrenergic receptor stimulation protocol. Figure 1 shows original recordings of all eight sequences of cardiac pacing-induced blood pressure oscillations obtained from 1 of the 11 rats during control conditions. In this experiment, the regulator was programmed to induce sinusoidal blood pressure oscillations with frequencies ranging from 0.016 to 0.5 Hz and amplitudes of Ϯ10 mmHg around a mean blood pressure of 90 mmHg. Therefore, mean blood pressure oscillated between 80 and 100 mmHg. The pronounced fluctuations in heart rate were elicited by the computer-regulated pacemaker. These computer-imposed heart rate fluctuations manipulate cardiac output, which only secondarily affects arterial blood pressure. Therefore, using our experimental setup, cardiac output does not truly "respond" to fluctuations in arterial blood pressure. However, vascular resistance clearly "responds" to changes in arterial blood pressure via 1) passive distension and elastic recoil, 2) the baroreflex that functions to reduce changes in blood pressure in the face of changes in cardiac output, and 3) myogenic responses that work at the whole body level in an "anti-baroreflex" manner to amplify changes in pressure induced by changes in cardiac output. The consequence of potent baroreflex responses (and of passive distension/recoil) is that large changes in cardiac output produce small changes in blood pressure. Thus, in the presence of a strong baroreflex, cardiac output needs to be perturbed more to achieve a given fluctuation in arterial blood pressure. This is clearly apparent in Fig.  2 , which shows larger amplitudes of mean cardiac output during blood pressure oscillations at high frequencies (cycle lengths of 5 s and less) than during blood pressure oscillations at low frequencies (cycle lengths of Ͼ5 s). This observation suggests that baroreflex function is most effective at frequencies above 0.2 Hz. The consequence of potent myogenic responses is that small changes in cardiac output can produce large changes in blood pressure. Again, this is clearly apparent in Fig. 2 , which shows smaller amplitudes of mean cardiac output during blood pressure oscillations at low frequencies (cycle lengths of 20 s and longer) than during blood pressure oscillations at high frequencies (cycle lengths of Ͻ20 s), suggesting that myogenic vascular function and/or whole body autoregulation of blood flow is most effective at frequencies below 0.05 Hz. This later overall pattern of response when inverted, namely the observation of little change in cardiac output associated with large changes in blood pressure, is reminiscent of autoregulation of blood flow to an individual organ, and we use the term herein at the whole body level for convenience.
A more quantitative way to study these response patterns is to perform transfer function analysis with cardiac output as the input function and mean blood pressure as the output function (Fig. 3) . The gain of this transfer function is a measure of how much mean blood pressure changes for a given change in cardiac output. The phase of ϳ0 rad at a frequency of 0.1 Hz indicates passive vascular responses. At this frequency, the normalized gain is Ͻ1.0, indicating that passive distension and elastic recoil oppose cardiac output-induced changes in arterial blood pressure. At frequencies of Ͼ0.2 Hz (inflection point), the phase deviates from 0 rad (significant at 0.5 Hz for control conditions and at 0.33 and 0.5 Hz for ␣ 1 -adrenergic stimulation), and the normalized gain decreases (significant at 0.5 Hz for control conditions and at 0.33 and 0.5 Hz for ␣ 1 -adrenergic stimulation), which is consistent with the baroreflex limiting the blood pressure response to changes in cardiac output. Finally, at frequencies Ͻ0.066 Hz for control conditions and Ͻ0.05 Hz for ␣ 1 -adrenergic stimulation (inflection points), the phase also deviates from 0 rad (significant at 0.016 Hz for control conditions and at 0.033 Hz for ␣ 1 -adrenergic stimulation), but the normalized gain increases (significant at 0.05 Hz and 0.016 Hz for control conditions and at 0.033 and 0.016 Hz for ␣ 1 -adrenergic stimulation), which indicates that small changes in cardiac output causes large changes in blood pressure, which can be seen as the consequence of potent myogenic responses.
Another interesting observation is that there is an almost perfect inverse relation between pacing-induced HR oscillations and resulting oscillations in stroke volume (Fig. 2) at lower frequencies (Յ0.1 Hz, cycle length Ն10 s). At a frequency of 0.2 Hz (cycle length 5 s), this relationship is no longer perfectly inverse, and at a frequency of 0.5 Hz (cycle length 2 s) heart rate and stroke volume change in the same direction. This phase shift between heart rate and stroke volume explains why at low frequencies large heart rate oscillations cause small fluctuations in cardiac output, whereas at high frequencies small heart rate oscillations cause large fluctuations in cardiac output.
During ␣ 1 -adrenergic receptor stimulation (phenylephrine infusion), mean blood pressure was significantly higher, and heart rate, cardiac output, and vascular conductance were significantly lower than during control conditions ( Fig. 4 ; P Ͻ 0.05 for factor "experimental condition" in two-way ANOVA). The decrease in heart rate in response to the phenylephrineinduced increase in blood pressure indicates a functional baroreceptor-heart rate reflex despite anesthesia. There was no significant effect of the frequency of pacing-induced blood pressure oscillations on any hemodynamic parameters (twoway ANOVA), suggesting that stable cardiovascular conditions were maintained throughout the experimental protocol.
The results of the transfer function analyses between mean blood pressure and cardiac output and between mean blood pressure and total peripheral vascular conductance are shown in Figs. 5 and 6. During control conditions and ␣ 1 -adrenergic receptor stimulation, coherence was Ն0.75 for all pacinginduced blood pressure oscillation frequencies and for both transfer functions. This finding indicates strong linear correlations between mean blood pressure and cardiac output and between mean blood pressure and vascular conductance. In general, the absolute gains of both transfer functions were smaller during ␣ 1 -adrenergic receptor stimulation than during control conditions (P Ͻ 0.05 for factor "experimental condition" in two-way ANOVA). This finding is consistent with greater vascular tone during ␣ 1 -adrenergic receptor stimula- Fig. 2 . Magnified view of (from top to bottom) mean BP, mean CO, HR, and stroke volume (SV) obtained during control conditions (same rat as in Fig. 1 ) for all eight sequences of pacing-induced BP oscillations with ranging from 60 s down to 2 s. Note that the amplitudes of the mean CO oscillations decline as the increase (from right to left), indicating the presence of autoregulation of CO at lower oscillation frequencies. The vertical lines mark the time points at which HR starts to increase within a pacing-induced BP oscillation cycle.
tion, resulting in reduced vascular compliance with less passive distention or elastic recoil in response to increases or decreases in intravascular pressure, respectively.
The normalized gains of the transfer functions revealed distinctive frequency response characteristics of the responses in cardiac output and vascular conductance to changes in mean blood pressure. First, in the frequency range between 0.05 and 0.2 Hz, the normalized gains of the transfer functions were relatively constant with values of ϳ2.0 and ϳ1.0 for the transfer functions between mean blood pressure and cardiac output and mean blood pressure and vascular conductance, respectively. These gains are consistent with a highly compliant vasculature that mainly responds passively to pressure changes. At frequencies Ͻ0.033 Hz (control conditions) and Ͻ0.05 Hz (␣ 1 -adrenergic stimulation) , the normalized gains of the transfer functions declined (inflection points in Figs. 5 and 6) as would be expected from autoregulation of blood flow, i.e., fluctuations in blood pressure elicit smaller changes in cardiac output, because the effects of passive distention and elastic recoil on vascular conductance are opposed by active myogenic vascular responses. It is important to point out that, during ␣ 1 -adrenergic receptor stimulation, the normalized gains started to decline at a higher frequency (inflection point at 0.05 Hz) than during control conditions (inflection point at 0.033 Hz). This finding is consistent with the well described facilitation of myogenic vascular function by ␣ 1 -adrenergic Fig. 4 . Mean BP, HR, CO, and total peripheral vascular conductance (VC) during control conditions (NaCl) and ␣1-adrenergic receptor stimulation using Phe for all eight frequencies of pacing-induced BP oscillations (x-axes). *Significant difference for the comparison between control conditions and ␣1-adrenergic receptor stimulation in two-way ANOVA (P Ͻ 0.05). Fig. 3 . Transfer function analysis between CO and mean BP during control conditions (NaCl infusion) and during ␣1-adrenergic receptor stimulation by phenylephrine (Phe) infusion. Top to bottom: squared coherence function (␥ 2 ), absolute gain of the transfer function ( H ), normalized gain of the transfer function (norm. H ), and phase of the transfer function (⌽). The arrows indicate inflection points, where the normalized gain abruptly increases or decreases from more constant values of ϳ0.1 Hz (gray arrow: control condition; black arrow: ␣1-adrenergic receptor stimulation). *Significant difference for the comparison between control conditions and ␣1-adrenergic receptor stimulation (2-way ANOVA; P Ͻ 0.05). †Significant difference for the comparison with the normalized gain at the inflection point during control conditions (P Ͻ 0.05). ‡Significant difference for the comparison with the normalized gain at the inflection point during ␣1-adrenergic receptor stimulation (P Ͻ 0.05).
n Significant difference for the comparison with the phase at 0.1 Hz during control conditions (P Ͻ 0.05).
p Significant difference for the comparison with the phase at 0.1 Hz during ␣1-adrenergic receptor stimulation (P Ͻ 0.05).
receptor stimulation (6, 34) . At frequencies above 0.2 Hz (inflection point), the normalized gains of the transfer functions increased (significant at 0.5 Hz for transfer function to cardiac output and at 0.33 and 0.5 Hz for transfer function to vascular conductance) as would be expected from baroreceptor reflexlike responses, i.e., baroreflex-mediated active vasodilation or vasoconstriction add to passive distention and elastic recoil in response to increases and decreases in blood pressure, respectively.
The passive response of the vasculature in the frequency range between 0.05 and 0.2 Hz is also reflected in the phases of the transfer functions that are close to 0 rad for inducedblood pressure oscillations at 0.1 Hz. A phase of 0 rad indicates an immediate response in cardiac output or vascular conductance to a change in pressure as would be expected from a passively responding vasculature. At lower and higher frequencies than 0.1 Hz, the phases generally increased (reaching significant values at various frequencies as indicated in Figs. 5  and 6 ), indicating that cardiac output and vascular conductance only respond to changes in pressure after certain time delays that are related to myogenic vascular responses and transmission times in the baroreflex loop.
The sensitivity of the baroreceptor-heart rate reflex was determined to investigate whether the baroreflex was functional despite anesthesia (Fig. 7) . During control conditions (saline infusion) the sensitivity of the reflex was Ϫ0.97 Ϯ 0.21 beats ⅐ min Ϫ1 ⅐ mmHg Ϫ1 . In four rats, baroreceptor-heart rate reflex sensitivity was also determined during ␣ 1 -adrenergic receptor stimulation (phenylephrine infusion). Under these conditions, baroreflex sensitivity was Ϫ0.78 Ϯ 0.38 beats ⅐ min Ϫ1 ⅐ mmHg Ϫ1 and not significantly different from control conditions.
DISCUSSION
The major new finding of this study is that whole body autoregulation of blood flow in rats is most effective in buffering pressure-induced oscillations in cardiac output at frequencies of Ͻ0.05 Hz, which coincides with the lower end of VLF (0.02-0.2 Hz) BPV in rats. This frequency range appears to be modulated by sympathetic vascular tone. Furthermore, Fig. 6 . Transfer function analysis between mean BP and total peripheral VC. Please refer to legend of Fig. 3 for explanation of abbreviations and symbols. The frequency response characteristics of the vascular responses to blood pressure oscillations identified in this study can be classified into three frequency bands based on the normalized gains of the transfer functions between mean blood pressure and cardiac output (Fig. 5 ) and between mean blood pressure and vascular conductance (Fig. 6) . First, at frequencies between 0.0167 and 0.033 Hz (control conditions) and between 0.0167 and 0.05 Hz (␣ 1 -adrenergic stimulation), the normalized gains increased continuously. Second, at frequencies between 0.033 and 0.2 Hz (control conditions) and 0.05 and 0.2 Hz (␣ 1 -adrenergic stimulation), the normalized gains were relatively constant. Third, at frequencies above 0.2 Hz, the normalized gains increased continuously up to 0.5 Hz, which was the highest frequency tested. In the following, we will discuss the physiological mechanisms potentially mediating the vascular responses to blood pressure fluctuations in these three frequency bands.
In the frequency range centered around 0.1 Hz, the results of the transfer functions are consistent with passive responses in a compliant vasculature. The phases of the transfer functions were close to 0 rad at the center frequency (0.1 Hz) of this frequency band, which indicates that cardiac output and vascular conductance respond instantaneously to changes in mean blood pressure. This lack of a time delay between the stimulus and the response is a hallmark sign of passive vascular responses. Furthermore, the normalized gains were 2.0 and 1.0 for the transfer functions between mean blood pressure and cardiac output and between mean blood pressure and vascular conductance, respectively. In a totally stiff vasculature without compliance, the normalized gains would be 1.0 and 0.0 for these two transfer functions, because a unit change in blood pressure would cause a similar unit change in cardiac output due to the higher perfusion pressure, and vascular conductance would not change, because in a stiff vasculature the diameter of the blood vessels would not change in response to fluctuations in intravascular pressure. However, in a compliant vasculature, the gains of the transfer functions are greater than in a stiff vasculature, because an increase in pressure distends the vasculature and increases vascular conductance (normalized gain to vascular conductance Ͼ 0), which allows for a greater cardiac output than would be expected solely based on the increased perfusion pressure (normalized gain to cardiac output Ͼ 1). Similarly, a reduction in pressure causes elastic recoil of the blood vessels and reduces vascular conductance, which causes a greater drop in cardiac output than what would be expected solely from the reduction in perfusion pressure. It is important to note that the normalized gain of 2.0 for the transfer function to cardiac output indicates that, due to the compliant properties of the overall vasculature, the amplitudes of the oscillations in cardiac output were actually twice as much as would be expected simply based on the fluctuations in perfusion pressure alone.
When the frequencies of the pacing-induced blood pressure oscillations were lowered below 0.033 Hz (control conditions) or 0.05 Hz (␣ 1 -adrenergic stimulation), the normalized gains of the transfer functions declined, and the phases deviated from 0 rad. These findings indicate that mechanisms that only respond after a certain time delay antagonize the passive pressureinduced changes in cardiac output and vascular conductance. It is reasonable to believe that these mechanisms are autoregulation of blood flow, buffering pressure-induced fluctuations in cardiac output and myogenic vascular function, opposing passive distention or elastic recoil in response to increases or decreases in intravascular pressure. Under control conditions, the effects of autoregulation of blood flow and/or myogenic vascular function were only significant at pacing-induced blood pressure oscillations with a frequency of 0.0167 Hz. However, during ␣ 1 -adrenergic receptor stimulation, the effect of autoregulation of blood flow was already apparent in the transfer function to cardiac output at the next higher frequency of 0.033 Hz. This finding is consistent with the well known facilitation of myogenic vascular function by ␣-adrenergic receptor stimulation (6, 34) and adds additional support to the notion that the decrease in normalized gain of the transfer functions at these lower frequencies is indeed due to mechanisms related to autoregulation of blood flow and/or myogenic vascular function. Furthermore, it illustrates that the frequency range where dynamic autoregulation of blood flow and/or myogenic vascular function modulates vascular responses to fluctuations in blood pressure is not constant. Specifically, increased sympathetic tone directed to the vasculature seems to expand this frequency range to higher frequencies. During pacing under control conditions, blood pressure was 10 -20 mmHg below baseline values without pacing. It is possible that this lower average blood pressure caused sympathetic nervous system activation that facilitated myogenic vascular function similar to ␣ 1 -adrenergic receptor stimulation. Such a mechanism may explain the relatively modest difference in the frequency response characteristic between control conditions and ␣ 1 -adrenergic receptor stimulation that only concerned the frequency of 0.033 Hz. It is also important to note that the decrease in the normalized gains of the transfer functions at frequencies Ͻ0.033 Hz (control conditions) or Ͻ0.05 Hz (␣ 1 -adrenergic stimulation) cannot be explained by mechanisms related to the baroreceptor reflex, because such mecha- Fig. 7 . Changes in HR (⌬HR) in response to changes in systolic BP (⌬BPSYS) elicited by intravenous bolus injections of varying doses of sodium nitroprusside and Phe during control conditions (NaCl; n ϭ 11) and during ␣1-adrenergic receptor stimulation with Phe (Phe; n ϭ 4). The gain of the baroreceptor-HR reflex was determined individually for each rat, and experimental conditions were based on the slope of a regression line fitted through the linear portion of the relationship between ⌬HR and ⌬BPSYS.
nisms would increase and not decrease the gains of the transfer functions as explained in the next paragraph.
At pacing-induced blood pressure oscillations with frequencies Ͼ0.2 Hz, the normalized gains of the transfer functions and the phases increased with increasing frequencies (P Ͻ 0.05, except at 0.33 Hz for the normalized gain of the transfer function to cardiac output, where P Ͻ 0.1). The increasing phases indicate a constant time delay between perturbations in mean blood pressure and resulting changes in cardiac output or vascular conductance. The greater normalized gains of the transfer function to vascular conductance at frequencies Ͼ0.2 Hz compared with the normalized gain at the inflection point at 0.2 Hz indicates that an increase in blood pressure causes a greater increase in vessel diameter and that a decrease in blood pressure causes a greater decrease in vessel diameter than would be expected just from passive distension and elastic recoil, respectively. Such a response pattern is consistent with baroreceptor reflex-mediated vascular effects because activation of the baroreceptors by an increase in blood pressure will reduce sympathetic nerve activity, leading to vasodilation, and unloading of the baroreceptors by a decrease in blood pressure will increase sympathetic tone, leading to vasoconstriction. Thus the phases, suggesting a constant time delay, together with the increasing normalized gains strongly indicate that vascular responses to blood pressure fluctuations at frequencies Ͼ0.2 Hz are largely mediated by the vascular component of the baroreceptor reflex.
Based on the opposing actions of myogenic vascular function and of the baroreceptor reflex on vascular responses to changes in pressure, one may argue that the responses at frequencies around 0.1 Hz are the result of the combination of myogenic vascular function and of the baroreceptor reflex rather than just passive vascular responses. Although we cannot completely rule out this possibility, the phase of ϳ0 rad at pacing-induced blood pressure oscillations at a frequency of 0.1 Hz makes this possibility less likely. It is known that myogenic vascular responses are much slower than sympathetic-mediated vascular responses (14, 27, 29) . Therefore, a combination of the opposing effects of myogenic vascular function and of the baroreceptor reflex on vascular responses to changes in pressure would not be expected to result in a phase of 0 rad.
The results of this study indicate that whole body autoregulation of blood flow in anesthetized rats only operates at relatively low frequencies of Ͻ0.05 Hz. At higher frequencies, passive changes in vessel diameter, affecting conductance, dominate the vascular response to fluctuations in perfusion pressure. These passive vascular responses are amplified by the baroreceptor reflex for blood pressure fluctuations at frequencies Ͼ0.2 Hz. This frequency response characteristic implies that blood pressure fluctuations at frequencies Ͼ0.05 Hz cause fluctuations in vascular conductance and cardiac output that are not opposed by whole body autoregulation but are amplified by the compliant properties of the vasculature and (at frequencies Ͼ0.2 Hz) by the baroreflex. For example, sinusoidal blood pressure oscillations with a cycle length of 15 s (0.0667 Hz) cause 7.5-s-long decreases in cardiac output every 15 s. These repetitive decreases in cardiac output may critically impair organ perfusion because they are not opposed by autoregulation of blood flow. If the brain were affected by such prolonged decreases in perfusion, dizziness or even fainting may occur. Fortunately, the frequency response characteristic of autoregulation of cerebral blood flow differs from whole body autoregulation in that it operates up to frequencies of 0.1 Hz (corresponding to a cycle length of 10 s) (14, 37) . Due to this faster autoregulation of cerebral blood flow compared with whole body autoregulation, the brain is normally able to prevent prolonged decreases in perfusion.
Taken together, the results of this study demonstrate that in anesthetized rats whole body autoregulation of blood flow operates most effectively at frequencies Ͻ0.05 Hz, which is consistent with the lower range of VLF BPV. These dynamic properties of whole body autoregulation of blood flow appear to be modulated by sympathetic vascular tone, facilitating myogenic vascular function. At frequencies between 0.05 and 0.2 Hz, the vasculature responds mainly passively to pressure fluctuations, and at frequencies Ͼ0.2 Hz the baroreceptor reflex amplifies these passive vascular responses. Based on these findings, we propose that VLF BPV largely depends on systemic myogenic vascular function and/or whole body autoregulation of blood flow.
